Anti-corruption action center is planning to hold a presentation of the analytical report “Who Makes Money on Epidemic of HIV/AIDs and Tuberculosis in Ukraine”, which will take place on December 13, 2013.
This is first case-study report produced by Anti-corruption Action Center (AntAC), which reveals intrinsic link between corruption and saving human lives. Corruption, staged competition, abuse of commercial secrets, and speculations on tenders prevent Ukraine from overcoming the epidemics of HIV/AIDS and tuberculosis (TB), both of which have threatened the country’s national security. This is the conclusion analysts at the AntAC came to after monitoring the public procurement of medicines for HIV/AIDS and TB in 2013.
In early 2013, the AntAC launched in-depth monitoring over the process of public procurement of medicines for HIV/AIDS and TB, challenging discovered violations and cases of inefficient spending from the state budget, and examining the structure of pharmaceutical company-supplier ownership. Assisted by members of the national chapter of Global Organization of Parliamentarians Against Corruption, AntAC experts demanded that law enforcement and regulatory agencies react to these alleged violations.
AntAC experts will describe four ways by which taxpayers’ money, allocated to purchase drugs for patients, ends up in the private pockets of pharmaceutical company owners in Ukraine. All schemes will be illustrated by examples of recent fishy medicines procurements.
The executive summary of the report is available here.